Exact Mass: 308.95714180000004
Exact Mass Matches: 308.95714180000004
Found 63 metabolites which its exact mass value is equals to given mass value 308.95714180000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Potassium citrate
Alkalising and buffering agent. It is used in foods, beverages and oral pharmaceutical formulations. More sol. than Na salts; also used in low-Na foods and as a potassium source in nutritional supplements. Potassium citrate is an effective way to treat/manage gout and arrhythmia, if the patient is hypokalemic. In common with other substances that render the urine alkaline, it may be used to reduce the danger of crystalluria during sulfonamide therapy. Potassium citrate is found in beverages. Alkalising and buffering agent. It is used in foods, beverages and oral pharmaceutical formulations. More sol. than Na salts; also used in low-Na foods and as a potassium source in nutritional supplements
5-BROMO-2-CHLORO-N-PHENYLBENZAMIDE
C13H9BrClNO (308.95559940000004)
ethyl 6-bromo-8-methyl-4-oxo-1H-quinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
5-(CHLOROMETHYL)-2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOLE
N-(4-Bromophenyl)-4,4,4-trifluoro-3-oxobutanamide
C10H7BrF3NO2 (308.96122180000003)
3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine
2-[(4-BROMOPHENYL)THIO]NICOTINIC ACID
C12H8BrNO2S (308.94590880000004)
2-Bromo-N-(4-chlorophenyl)benzamide
C13H9BrClNO (308.95559940000004)
4-BROMO-N-(FURAN-2-YLMETHYL)-3-METHOXYBENZAMIDE
C13H12BrNO3 (309.00005020000003)
5-Bromo-1-(4-methoxybenzyl)-1H-pyrrole-2-carboxylic acid
C13H12BrNO3 (309.00005020000003)
2,5-Cyclohexadien-1-one,4-[[4-(acetyloxy)phenyl]imino]-2,6-dichloro-
Ethanone,2-chloro-1-(2-chloro-10H-phenothiazin-10-yl)-
ethyl 4-bromo-6-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
2-amino-5-bromo-2-chlorobenzophenone
C13H9BrClNO (308.95559940000004)
3-(3-chlorophenyl)-4-cyano-5-methylsulfanylthiophene-2-carboxylic acid
3-(4-CHLOROPHENYL)-4-CYANO-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
[2-(3-bromo-phenyl)-ethyl]-(4-chloro-phenyl)-amine
C14H13BrClN (308.9919828000001)
6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide
4-Bromo-N-(4-chlorophenyl)benzamide
C13H9BrClNO (308.95559940000004)
5-chloro-N-(2,4-difluorophenyl)thiophene-2-sulfonamide
ethyl 4-bromo-8-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
4-ISOXAZOLECARBOXYLIC ACID, 5-(4-BROMOPHENYL)-3-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
4-bromo-N-(tert-butyl)-2-fluorobenzenesulfonamide
C10H13BrFNO2S (308.98343500000004)
5-bromo-n-(2-hydroxyethyl)-2-methoxybenzenesulfonamide
2-(5-bromo-4-oxopentyl)isoindole-1,3-dione
C13H12BrNO3 (309.00005020000003)
4-[(4-CHLOROPHENYL)SULFANYL]-3-NITROBENZENECARBOXYLIC ACID
C13H8ClNO4S (308.98625580000004)
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-BROMOPHENYL)-5-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
Anagrelide hydrochloride monohydrate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent
5-Hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 5-hydroxylation followed by oxidation.
6-Amino-5-[(4-chlorophenyl)sulfonyl]-2-hydroxynicotinonitrile
C12H8ClN3O3S (308.99748880000004)
Tripotassium;2-hydroxypropane-1,2,3-tricarboxylic acid
N-[(E)-(5-bromothiophen-2-yl)methylideneamino]pyridine-2-carboxamide
C11H8BrN3OS (308.95714180000004)
4-hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 4-hydroxylation followed by oxidation.